Glaukos Corporation (GKOS)
NYSE: GKOS · IEX Real-Time Price · USD
106.73
+0.21 (0.20%)
May 6, 2024, 11:25 AM EDT - Market open
Glaukos Employees
Glaukos had 907 employees on December 31, 2023. The number of employees increased by 124 or 15.84% compared to the previous year.
Employees
907
Change (1Y)
124
Growth (1Y)
15.84%
Revenue / Employee
$359,905
Profits / Employee
-$155,318
Market Cap
5.37B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 907 | 124 | 15.84% |
Dec 31, 2022 | 783 | 56 | 7.70% |
Dec 31, 2021 | 727 | 74 | 11.33% |
Dec 31, 2020 | 653 | 53 | 8.83% |
Dec 31, 2019 | 600 | 163 | 37.30% |
Dec 31, 2018 | 437 | 50 | 12.92% |
Dec 31, 2017 | 387 | 123 | 46.59% |
Dec 31, 2016 | 264 | 82 | 45.05% |
Dec 31, 2015 | 182 | 56 | 44.44% |
Dec 31, 2014 | 126 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
R1 RCM | 30,000 |
Grifols | 23,737 |
Acadia Healthcare Company | 23,500 |
DENTSPLY SIRONA | 15,000 |
Option Care Health | 7,802 |
Ionis Pharmaceuticals | 927 |
Lantheus Holdings | 834 |
Apellis Pharmaceuticals | 702 |
GKOS News
- 4 days ago - Glaukos Announces First Quarter 2024 Financial Results - Business Wire
- 19 days ago - Glaukos Announces the Release of its 2023 Sustainability Report - Business Wire
- 26 days ago - Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1 - Business Wire
- 4 weeks ago - Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant) - Business Wire
- 5 weeks ago - Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting - Business Wire
- 2 months ago - Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 3 months ago - Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21 - Business Wire
- 4 months ago - Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance - Business Wire